Clinical Trial

Open-Label Clinical Trial Evaluating the Impact of a Multi-Strain Commensal Probiotic Dietary Supplement on Gastrointestinal Microbiota Composition, Functional Gastrointestinal Markers, and Gastrointestinal Symptoms

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
A single-arm, open-label prospective study will be conducted evaluating the impact of 8 weeks of supplementation at the manufacturer-recommended dose of Complete Commensal Probiotic™ on the GI-MAP stool test panel (Diagnostic Solutions Laboratory, Alpharetta, GA), gastrointestinal symptoms, digestion-associated quality of life. and overall physical health, mental health, and anxiety.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-07-17.
Trial Details
NCT Number NCT07720362
Lead Sponsor OvationLab
Conditions Gastrointestinal, Microbiota
Enrollment 25 participants
Start Date 2026-07-21
Primary Completion 2026-11 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2026-07-23